Wire Stories

GC Biopharma Celebrates ‘World Hemophilia Day’

YONGIN, South Korea--(BUSINESS WIRE)--GC Biopharma (006280.KS), a South Korean biopharmaceutical company, takes part in a campaign to celebrate World Hemophilia…

5 years ago

DiDi to Hold Extraordinary General Meeting on May 23, 2022

BEIJING--(BUSINESS WIRE)--DiDi Global Inc. (“DiDi” or the “Company”) (NYSE: DIDI) today announced that it will hold an extraordinary general meeting…

5 years ago

DiDi Global Announces Unaudited Quarterly Financial Results

BEIJING--(BUSINESS WIRE)--DiDi Global Inc. (“DiDi” or the “Company”) (NYSE: DIDI), the world’s leading mobility technology platform, today announced its unaudited…

5 years ago

Pension Funds Should Divest of Cue Group Owned in KKR Fund, says UFCW; New UFCW Website Details Cue’s Collaboration with China’s Surveillance Agency

WASHINGTON--(BUSINESS WIRE)--United Food and Commercial Workers International Union calls on public pension funds invested in KKR Asian Fund III to…

5 years ago

CyberLink Announces the Integration of Its FaceMe® Security Facial Recognition Software with AXIS Camera Station

The end-to-end integration brings FaceMe’s industry-leading facial recognition functionalities to AXIS camera and VMS setups, fusing live stream monitoring and…

5 years ago

Bandai Namco Entertainment 021 Startup Investment Fund Aims to Accelerate New Forms of Entertainment

TOKYO--(BUSINESS WIRE)--Bandai Namco Entertainment Inc. has launched the Bandai Namco Entertainment 021 (Zero to One) Fund, a new investment fund…

5 years ago

China Cranes Market Report: Historical Data (2011, 2016 and 2021) and Long-term Forecasts through 2026 and 2031 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Cranes Markets in China" report has been added to ResearchAndMarkets.com's offering. China's demand for Cranes has grown at…

5 years ago

Key Trends and Opportunities in the Hong Kong Life Insurance Market to 2025 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Hong Kong Life Insurance - Key Trends and Opportunities to 2025" report has been added to ResearchAndMarkets.com's offering.…

5 years ago

China NMPA Approves Tislelizumab for Patients with Second-Line Esophageal Squamous Cell Carcinoma

Tislelizumab is now approved for eight indications in China CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING--(BUSINESS WIRE)--BeiGene, Ltd. (NASDAQ: BGNE;…

5 years ago